
We see two challenges in the AI space specific to the US. First, the world’s biggest large language model (LLM) player, OpenAI, has been losing market share in the enterprise space to Anthropic and Alphabet. This casts doubt on OpenAI’s ability to raise funds. Meanwhile, OpenAI has made several significant deals with a total estimated value of over USD1.4tn in future commitments for GPUs and cloud infrastructure. If OpenAI continues to lose market share and is unable to raise funds, there is a risk of it not being able to fulfil orders with Oracle, Broadcom etc. On the other hand, key LLM players in China such as Alibaba, TikTok, and Baidu are not reliant on external funding to fulfill their capex commitments. Second, we see challenges in the US data-centre space where power crunch is causing significant delays for new DC projects. Northern Virginia – the largest DC market in the US – is facing severe grid congestion while cities like Phoenix, Dallas, and Atlanta are reporting 2–5 year wait times for new capacity. Meanwhile, we don’t see any power crunch in China as many hyperscalers’ DCs are already operating in remote regions with abundant cheap power. The third challenge is the recent surge in memory prices due to manufacturers diverting their production towards high-margin high bandwidth memory (HBM) for AI. This has caused a memory supply shortage for consumer electronics (PCs, smartphones) which are forced to pass down the costs to consumers.
China is also accelerating the build-out of a domestic AI chip ecosystem. There were four AI chip IPOs completed across China onshore and in Hong Kong since 4Q25, boosting sentiment. Meanwhile, Baidu has proposed a spin-off to separately list its AI chip arm Kunlunxin, and Alibaba is reportedly preparing an IPO for its chip unit T-Head. Equally important, domestic accelerators are being paired with maturing software stacks that reduce developer switching costs. This is done either via CUDA alternatives (e.g., Moore Threads’ MUSA) or other CUDA compatibility architecture for model training. Domestic stacks are progressing from inference to training-grade workloads and are gradually reducing reliance on imported chips especially from Nvidia over time. As such, we see China’s domestic chip developers are pushing for a multi-year substitution cycle rather than a short-term policy trade.
We prefer full-stack AI players such as Alibaba, Baidu in China, and Alphabet in the US. These companies span the AI value chain from chips and cloud to LLM and end-user applications. This matters because vertical integration offers immediate monetisation via chips and cloud in the near term, and applications in the medium term, while other carve-outs (Kunlunxin; T-Head) can act as valuation catalysts. Alibaba’s open-source LLM Qwen has surpassed 700mn cumulative downloads on Hugging Face, while Baidu’s overseas cloud app TeraBox (c.400mn global users), and other Chinese AI applications, such as Kuaishou’s Kling with 60mn+ creators worldwide, are increasingly signing up global users. Among the US players, we prefer Alphabet for its ability to break the monopoly of OpenAI in LLM and Nvidia in GPUs for training.
Figure 1: OpenAI losing enterprise market share to Anthropic and Alphabet
Source: Menlo Ventures, DBS
Download the PDF to read the full report.
DISCLAIMERS AND IMPORTANT NOTES
This information herein is published by DBS Bank Ltd. (“DBS Bank”) and is for information only. This publication is intended for DBS Bank and its subsidiaries or affiliates (collectively “DBS”) and clients to whom it has been delivered and may not be reproduced, transmitted or communicated to any other person without the prior written permission of DBS Bank.
This publication is not and does not constitute or form part of any offer, recommendation, invitation or solicitation to you to subscribe to or to enter into any transaction as described, nor is it calculated to invite or permit the making of offers to the public to subscribe to or enter into any transaction for cash or other consideration and should not be viewed as such.
The information herein may be incomplete or condensed and it may not include a number of terms and provisions nor does it identify or define all or any of the risks associated to any actual transaction. Any terms, conditions and opinions contained herein may have been obtained from various sources and neither DBS nor any of their respective directors or employees (collectively the “DBS Group”) make any warranty, expressed or implied, as to its accuracy or completeness and thus assume no responsibility of it. The information herein may be subject to further revision, verification and updating and DBS Group undertakes no responsibility thereof.
All figures and amounts stated are for illustration purposes only and shall not bind DBS Group. DBS Group does not act as an adviser and assumes no fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any arrangement or entrance into any transaction in reliance on the information contained herein. The information herein does not have regard to the investment objectives, financial situation and particular needs of any specific person. In order to build your own independent analysis of any transaction and its consequences, you should consult your own independent financial, accounting, tax, legal or other competent professional advisors as you deem appropriate to ensure that any assessment you make is suitable for you in light of your own financial, accounting, tax, and legal constraints and objectives without relying in any way on DBS Group or any position which DBS Group might have expressed in this document or orally to you in the discussion.
Companies within the DBS Group or the directors or employees of the DBS Group or persons/entities connected to them may have positions in and may affect transactions in the underlying product(s) mentioned. Companies within the DBS Group may have alliances or other contractual agreements with the provider(s) of the underlying product(s) to market or sell its product(s). Where companies within the DBS Group are the product provider, such company may be receiving fees from the investors. In addition, companies within the DBS Group may also perform or seek to perform broking, investment banking and other banking or financial services to the companies or affiliates mentioned herein.
This publication may include quotation, comments or analysis. Any such quotation, comments or analysis have been prepared on assumptions and parameters that reflect our good faith, judgement or selection and therefore no warranty is given as to its accuracy, completeness or reasonableness. All information, estimates, forecasts and opinions included in this document or orally to you in the discussion constitute our judgement as of the date indicated and may be subject to change without notice. Changes in market conditions or in any assumptions may have material impact on any estimates or opinion stated.
Prices and availability of financial instruments are subject to change without notice. Any information relating to past performance, or any future forecast based on past performance or other assumptions, is not necessarily a reliable indicator of future results. Future results may not meet our/ your expectations due to a variety of economic, market and other factors.
This publication has not been reviewed or authorised by any regulatory authority in Singapore, Hong Kong, Dubai International Financial Centre, United Kingdom or elsewhere. There is no planned schedule or frequency for updating research publication relating to any issuer.
If this publication has been distributed by electronic transmission, such as e-mail, then such transmission cannot be guaranteed to be secure or error-free as information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, or contain viruses. The sender therefore does not accept liability for any errors or omissions in the contents of the Information, which may arise as a result of electronic transmission. If verification is required, please request for a hard-copy version.
The investment product(s) mentioned herein is/are not the only product(s) that is/are aligned with the views stated in the research report(s) and may not be the most preferred or suitable product for you. There are other investment product(s) available in the market which may better suit your investment profile, objectives and financial situation.
This publication is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.
Country Specific Disclaimer
This publication is distributed by DBS Bank Ltd (Company Regn. No. 196800306E) ("DBS") which is an Exempt Financial Adviser as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore (the "MAS").
This publication is provided to you as an “Accredited Investor” (defined under the Securities and Futures Act of Singapore and the Securities and Futures (Classes of Investors) Regulations 2018) or an “Institutional Investor” (defined under the Securities and Futures Act of Singapore and the Securities and Futures (Classes of Investors) Regulations 2018) for your private use only and may not be passed on or disclosed to any person nor copied or reproduced in any manner.